Loading…
Evonile Pharma (NOVARTIND)₹1,758+2.61%Pharmaceuticals
At the end of the Sep 2026 quarter, Evonile Pharma's shareholders were: promoters 70.66%, FIIs 0.15%, DIIs 1.40%, public 27.79%. Promoter holding is unchanged on the quarter. FII holding is down 0.04 percentage points from 0.19% a year earlier. 0.00% of promoter shares were pledged. It had 36,697 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.66% | 70.66% | 70.66% | 70.66% | 70.66% | 70.66% | 70.66% | 70.66% | 70.66% | 70.66% | 70.66% | 70.66% |
| FIIs | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% | 0.17% | 0.16% | 0.15% |
| DIIs | 0.52% | 0.52% | 0.52% | 0.52% | 0.53% | 0.53% | 0.53% | 0.53% | 0.63% | 0.53% | 1.36% | 1.40% |
| Public | 28.63% | 28.63% | 28.63% | 28.63% | 28.62% | 28.62% | 28.62% | 28.62% | 28.51% | 28.64% | 27.82% | 27.79% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 43,117 | 41,229 | 39,255 | 39,586 | 38,916 | 39,123 | 39,030 | 39,343 | 39,458 | 38,107 | 36,493 | 36,697 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Waverise Investments Limited | Promoter | 56.47% | New |
| Chryscapital Fund X | Promoter | 10.28% | New |
| Two Infinity Partners | Promoter | 3.90% | New |
| Atul Limited | Public | 1.53% | 0.00 |
| Novartis Ag | Promoter | Exited | — |
Promoters held 70.66% of Evonile Pharma at the end of the Sep 2026 quarter, the same as a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 0.15% (down 0.01 percentage points from 0.16% a quarter earlier) and domestic institutions (DIIs) held 1.40% (up 0.04 percentage points from 1.36% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Evonile Pharma had 36,697 shareholders at the end of the Sep 2026 quarter, against 39,343 a year earlier.
Atul Limited (Public) held 1.53% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.